Literature DB >> 22886493

Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake.

Gitte Dam1, Susanne Keiding, Ole L Munk, Peter Ott, Hendrik Vilstrup, Lasse K Bak, Helle S Waagepetersen, Arne Schousboe, Michael Sørensen.   

Abstract

UNLABELLED: Studies have shown decreased cerebral oxygen metabolism (CMRO(2)) and blood flow (CBF) in patients with cirrhosis with hepatic encephalopathy (HE). It remains unclear, however, whether these disturbances are associated with HE or with cirrhosis itself and how they may relate to arterial blood ammonia concentration and cerebral metabolic rate of blood ammonia (CMRA). We addressed these questions in a paired study design by investigating patients with cirrhosis during and after recovery from an acute episode of HE type C. CMRO(2), CBF, and CMRA were measured by dynamic positron emission tomography (PET)/computed tomography (CT). Ten patients with cirrhosis were studied during an acute episode of HE; nine were reexamined after recovery. Nine patients with cirrhosis with no history of HE served as controls. Mean CMRO(2) increased from 0.73 μmol oxygen/mL brain tissue/min during HE to 0.91 μmol oxygen/mL brain tissue/min after recovery (paired t test; P < 0.05). Mean CBF increased from 0.28 mL blood/mL brain tissue/min during HE to 0.38 mL blood/mL brain tissue/min after recovery (P < 0.05). After recovery from HE, CMRO(2) and CBF were not significantly different from values in the control patients. Arterial blood ammonia concentration decreased 20% after recovery (P < 0.05) and CMRA was unchanged (P > 0.30); both values were higher than in the control patients (both P < 0.05).
CONCLUSION: The low values of CMRO(2) and CBF observed during HE increased after recovery from HE and were thus associated with HE rather than the liver disease as such. The changes in CMRO(2) and CBF could not be linked to blood ammonia concentration or CMRA.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22886493     DOI: 10.1002/hep.25995

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

Review 1.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

Review 2.  Effects of hyperammonemia on brain energy metabolism: controversial findings in vivo and in vitro.

Authors:  Arne Schousboe; Helle S Waagepetersen; Renata Leke; Lasse K Bak
Journal:  Metab Brain Dis       Date:  2014-03-01       Impact factor: 3.584

Review 3.  Pathophysiology, diagnosis, and management of hepatic encephalopathy.

Authors:  Christopher Sheasgreen; Lucy Lu; Ameen Patel
Journal:  Inflammopharmacology       Date:  2014-10-10       Impact factor: 4.473

Review 4.  The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy.

Authors:  M M Lauridsen; M Thiele; N Kimer; H Vilstrup
Journal:  Metab Brain Dis       Date:  2013-01-10       Impact factor: 3.584

5.  Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.

Authors:  Gang Zheng; Hanzhang Lu; Wenkui Yu; Song Luo; Ya Liu; Wei Liu; Hui Liu; Long Wu; Lijuan Zheng; Xiang Kong; Long Jiang Zhang; Guang Ming Lu
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

Review 6.  Cerebral effects of ammonia in liver disease: current hypotheses.

Authors:  Peter Ott; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-02-04       Impact factor: 3.584

7.  1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.

Authors:  Veronika Rackayova; Olivier Braissant; Valérie A McLin; Corina Berset; Bernard Lanz; Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2015-08-09       Impact factor: 3.584

Review 8.  Update on cerebral uptake of blood ammonia.

Authors:  Michael Sørensen
Journal:  Metab Brain Dis       Date:  2013-03-13       Impact factor: 3.584

9.  Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.

Authors:  Andreas W Fries; Sherry Dadsetan; Susanne Keiding; Lasse K Bak; Arne Schousboe; Helle S Waagepetersen; Mette Simonsen; Peter Ott; Hendrik Vilstrup; Michael Sørensen
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-18       Impact factor: 6.200

10.  Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy.

Authors:  Claude V Dennis; Pamela J Sheahan; Manuel B Graeber; Donna L Sheedy; Jillian J Kril; Greg T Sutherland
Journal:  Metab Brain Dis       Date:  2013-12-19       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.